| Story Views | |
| Now: | |
| Last Hour: | |
| Last 24 Hours: | |
| Total: | |
Gene therapy shows promise in eradicating some blood cancers
From
This is the same treatment that was described in a Nextbigfuture article yesterday. Novartis has the rights to this and is developing it.
“We believe we know why the two patients didn't respond,” said Penn physician David L. Porter, a cancer and blood specialist. “If we're right, it's something we can fix.”
The therapy, culminating 20 years of research, involves genetically engineering T cells – the immune system's big guns – to attack B cells, the blood component that turns malignant in chronic lymphocytic leukemia and acute lymphoblastic leukemia.
Interfering with the immune system, however, is dicey. From the start, it was clear the designer T cells had side effects that caused flulike symptoms.
See more and subscribe to NextBigFuture at 2012-12-14 09:23:14 Source: http://nextbigfuture.com/2012/12/gene-therapy-shows-promise-in.html
Source:
